Myasthenia gravis, polymyositis, and dermatomyositis represent disorders of the neuromuscular system in which a possible autoimmune aetiology has been suggested. These disorders have been investigated using several in vitro parameters that are considered to correlate with cell-mediated hypersensitivity (Bloom, 1971) . These include in vitro lymphocyte proliferative response, buffy coat migration inhibition, and direct cell-mediated lymphocytolysis of muscle cultures. Using such techniques, studies have been published suggesting that cell-mediated hypersensitivity to muscle is a concomitant and perhaps causative mechanism of both myasthenia gravis (Alpert et al., 1972; Goust et al., 1974) and polymyositis Johnson et al., 1972; Dawkins and Mastaglia, 1973; Esiri et al., 1973; Goust et al., 1974; Haas and Arnason, 1974) . Evidence has likewise been presented, using lymphocyte mediated cytotoxicity and inhibition of thymic cell migration, suggesting that there are cells within the myas-
Myasthenia gravis, polymyositis, and dermatomyositis represent disorders of the neuromuscular system in which a possible autoimmune aetiology has been suggested. These disorders have been investigated using several in vitro parameters that are considered to correlate with cell-mediated hypersensitivity (Bloom, 1971) . These include in vitro lymphocyte proliferative response, buffy coat migration inhibition, and direct cell-mediated lymphocytolysis of muscle cultures. Using such techniques, studies have been published suggesting that cell-mediated hypersensitivity to muscle is a concomitant and perhaps causative mechanism of both myasthenia gravis (Alpert et al., 1972; Goust et al., 1974) and polymyositis Johnson et al., 1972; Dawkins and Mastaglia, 1973; Esiri et al., 1973; Goust et al., 1974; Haas and Arnason, 1974) . Evidence has likewise been presented, using lymphocyte mediated cytotoxicity and inhibition of thymic cell migration, suggesting that there are cells within the myas-thenic thymus sensitized to muscle (Armstrong et al., 1973) . We sought to investigate the in vitro proliferative response to muscle extract in the peripheral blood of patients with myasthenia gravis as well as in patients with polymyositis and dermatomyositis and to compare these with the responses in blood lymphocytes of controls. The in vitro proliferative response of peripheral blood lymphocytes from such subjects were all assessed after stimulation by the non-specific mitogens, phytohaemagglutinin, and pokeweed mitogen. In addition, the proliferative responses induced by skeletal muscle were compared in thymic cells obtained from myasthenic patients and cardiac surgery patients.
METHODS
PATIENTS Patients with myasthenia gravis, defined by variable voluntary skeletal muscle weakness responsive to anticholinesterase administration (Simpson, 1969; Rowland and Layzer, 1973) (Pearson, 1969; Rowland and Layzer, 1973 Several patients were studied pre-and postthymectomy; no consistent pattern was noted in the responses of their lymphocytes to either mitogens or muscle extract. In the muscle extractthymic cell cultures, the mean SI of cells from myasthenic patients (2.2 + 0.6) was not statistically different from that of the control group (1.2 + 0.6). In one subject, where muscle extract induced an SI of 22 in blood lymphocytes, the SI in thymic cells cultured with muscle was 5.1.
DISCUSSION
In this study no evidence could be found for an obvious lymphocyte immunological defect in myasthenia, polymyositis, or dermatomyositis as manifested by deficient mitogen induced responses (Daguillard, 1972) . It is conceivable that a more subtle defect in generalized immune responsiveness might be demonstrated in any of the studied disease states utilizing other mitogens and varying durations of lymphocyte culture. However, in another study in which peripheral blood lymphocytes were isolated by Ficoll-Hypaque gradient centrifugation, there was no difference in the in vitro PHA or PWM induced proliferative response after three or five days of culture (Abdou et al., 1974) .
In this study, we found no consistent evidence of muscle extract stimulated in vitro proliferation of blood lymphocytes from myasthenics. It is true that a stimulation index of > 3 was seen in cells of two of 21 non-thymectomized myasthenics, whereas such stimulation was not seen in the lymphocytes of any of the normal subjects. However, the mean response to muscle of cells of the myasthenic group as a whole was not significantly different from that of normal subjects. It is of note that thymus cells of one of the two myasthenics with muscle stimulated blood lymphocytes were also stimulated by the muscle extract.
A search for in vitro evidence of cell-mediated reactivity to (Alpert et al., 1972; Goust et al., 1974 , but the responses in one of the reports were quite modest (mean SI-2.2). No stimulation index was described in the other study (Esiri et al., 1973 Dawkins and Mastaglia (1973) reported similar findings in cultures containing extracts of normal, rather than autologous, muscle. More recently, Haas and Arnason (1974) found increased creatine phosphokinase release from fetal muscle cultures in the presence of lymphocytes from patients with polymyositis.
In an approach using an electrophoretic macrophage migration inhibition test, it has been claimed (Caspary et al., 1971 ) that immune reactivity is present in lymphocytes of patients not only with polymyositis but also in patients with muscular dystrophy.
Although the methodology has varied in the reports just described, there is a suggestion of similar immunological reactivity against muscle in myasthenia and polymyositis. It would be somewhat surprising if such reactivity were pathogenetic in face of the disparate clinical features of the two disorders. It is possible that any immunological activity against muscle was a secondary event and/or an epiphenomenon. 
